Previsioni di mercato delle particelle simili a virus in Sud America fino al 2028 – Impatto del COVID-19 e analisi regionale per tipo di prodotto (epatite, cancro/HPV e malattia di Gaucher), fonte (lievito, cellule di insetti, piante e altri) e applicazione (vaccini) e terapeutico)

Introduzione al mercato

I principali paesi inclusi nell\'analisi per il Sud America includono Argentina, Brasile e resto del Sud America. La crescita del mercato delle particelle virus-simili nella regione è attribuita all’invecchiamento della popolazione, al fiorente mercato della diagnostica e alle crescenti iniziative dei principali attori dell’industria farmaceutica. È probabile che il mercato si spinga nel periodo previsto a causa dei recenti sviluppi tecnologici che hanno avuto un impatto diretto sull’economia del Brasile che è progredita in larga misura. Ogni anno in Sud America si verificano circa 100.000 casi di infezione acuta da virus dell’epatite B (HBV). La prevalenza complessiva dell’infezione da epatite B (HBV) nelle popolazioni a basso rischio varia dal 6,7% al 41%, mentre i tassi dell’antigene di superficie dell’epatite B (HBsAg) variano dallo 0,4% al 13%. Nelle popolazioni aborigene o rurali ad elevata endemicità, la trasmissione perinatale può svolgere un ruolo importante nella diffusione dell\'epatite B (HBV).

Mentre il Sud America diventa il nuovo epicentro del COVID-19 , crescono i timori di dipendere da un vaccino progettato e prodotto all’estero, soprattutto perché i paesi più ricchi hanno storicamente avuto un migliore accesso alle vaccinazioni. I governi del Sud America hanno agito in modo rapido e preventivo per salvaguardare i propri cittadini e controllare la diffusione del COVID-19 nell’area, nonché le sue conseguenze economiche. Secondo i rapporti, alcuni governi di paesi ad alto reddito hanno tentato di acquistare aziende produttrici di vaccini o una parte della loro fornitura. Secondo i ricercatori, rivestono particelle simili a virus con pezzi delle proteine che il coronavirus utilizza per entrare nelle cellule umane nella speranza di indurre il sistema immunitario a creare anticorpi che bloccheranno il coronavirus durante l’infezione. Poiché queste particelle non possono replicarsi all’interno del corpo umano e le particelle simili a virus sono considerate più sicure delle vaccinazioni create da virus indeboliti, la tecnologia è già stata utilizzata per sviluppare vaccini contro l’epatite B e il papillomavirus umano accessibili a livello commerciale. Inoltre, Argentina e Messico hanno siglato un accordo con mAbxience, la società farmaceutica britannica AstraZeneca e l’Università di Oxford nell’agosto 2020. L’obiettivo è creare tra 150 e 250 milioni di dosi del vaccino COVID-19, che sarà distribuito in tutto il Sud America. dovrebbe aiutare la regione nella lotta contro il COVID-19.

Panoramica e dinamiche del mercato

Si prevede che il mercato delle particelle virus-simili in Sud America crescerà da 199,78 milioni di dollari nel 2021 a 324,57 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 7,2% dal 2021 al 2028. I vaccini costituiscono uno dei segmenti significativi dell\'industria farmaceutica. Hanno una vasta applicazione nell\'immunizzazione degli esseri umani e degli animali contro le infezioni comuni. Le aziende che operano nei mercati farmaceutico e biofarmaceutico si concentrano continuamente sulle innovazioni e sugli sviluppi dei prodotti per sostenere la concorrenza sul mercato. Ad esempio, gli operatori del mercato hanno investito in modo significativo nello sviluppo di vaccini contro il COVID-19 e in studi relativi alla VLP. Gli sviluppi attivi da parte delle aziende del settore delle scienze della vita, insieme al sostegno del governo per le stesse, stanno contribuendo alla crescita del mercato VLP.

Segmenti chiave del mercato

In termini di tipologia di prodotto, il segmento dell\'epatite ha rappresentato la quota maggiore del mercato delle particelle simili a virus in Sud America nel 2021. In termini di fonte, il segmento del lievito ha rappresentato la quota maggiore del mercato delle particelle simili a virus in Sud America nel 2021. In termini di applicazione, il segmento dei vaccini ha detenuto una quota di mercato maggiore del mercato delle particelle simili a virus nel 2021.

Principali fonti e aziende elencate
Alcune principali fonti primarie e secondarie a cui si fa riferimento per la preparazione Questo rapporto sul mercato delle particelle simili a virus in Sud America comprende siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali società elencate nel rapporto sono Merck & Co., Inc.; GlaxoSmithKline plc.; Pfizer Inc.; Sanofi; Istituto del siero dell\'India Pvt. Ltd.; BIOTECNOLOGIA BHARAT; e LG Chem, tra gli altri.
Motivi per acquistare il rapporto
Comprendere il panorama del mercato delle particelle simili a virus in Sud America e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
Stai al passo con la corsa comprendendo il panorama competitivo in continua evoluzione per il mercato delle particelle simili ai virus in Sud America
In modo efficiente pianificare fusioni, acquisizioni e accordi di partnership nel mercato delle particelle simili a virus in Sud America identificando i segmenti di mercato con le vendite probabili più promettenti
Aiuta a prendere decisioni aziendali consapevoli grazie ad un\'analisi perspicace e completa della performance di mercato di vari segmenti del mercato delle particelle simili a virus in Sud America
Ottenere previsioni sui ricavi di mercato per il mercato in base ai vari segmenti dal 2021 al 2028 nella regione del Sud America.
Segmentazione del mercato delle particelle simili a virus in Sud America

Mercato delle particelle simili a virus in Sud America: per tipo di prodotto
Epatite
Cancro/HPV
Malattia di Gaucher
Mercato delle particelle simili a virus in Sud America: per fonte
Lievito
Cellula di insetto
Pianta
Altri
Mercato delle particelle simili a virus in Sud America - Di Applicazione
Vaccini
Terapia
Mercato delle particelle simili a virus in Sud America: per paese
Brasile
Argentina
Resto della SAM
Mercato delle particelle simili a virus in Sud America: aziende menzionate
Merck & Co., Inc. ;             \' bsp ;
GlaxoSmithKline plc.
Pfizer Inc. ;             \' bsp ;             \' bsp ;
Sanofi ;             \' bsp ;             \' bsp ;             \'
Serum Institute of India Pvt. Ltd.
BHARAT BIOTECH              ;                                ;
LG Chem ;             \' bsp ;           \'

1. Introduction
1.1         Scope of the Study
1.2         The Insight Partners Research Report Guidance
1.3         Market Segmentation
1.3.1        South America Virus-like Particles Market – By Product Type
1.3.2        South America Virus-like Particles Market – By Source
1.3.3        South America Virus-like Particles Market – By Application
1.3.4        South America Virus-like Particles Market – By Country
2.           South America Virus-like Particles Market – Key Takeaways
3.        Research Methodology
3.1         Coverage
3.2         Secondary Research
3.3         Primary Research
4.           South America Virus-like Particles Market Landscape
4.1         Overview
4.2         PEST Analysis
4.3         Experts Opinion
5.           South America Virus-like Particles Market – Key Market Dynamics
5.1         Market Drivers
5.1.1        Up-raising Prevalence of Infectious Viral Diseases
5.1.2        Surging Role of Virus-Like Particles in Therapeutic Developments and Studies
5.2         Market Restraints
5.2.1        Availableness of Alternative Technologies for Viral Vaccine Production
5.3         Market Opportunities
5.3.1        Scaling Potential Applications in Therapeutics and Diagnostics
5.4         Future Trends
5.4.1        Consistent Demand for Innovative and Effective Products
5.5         Impact Analysis
6.           South America Virus-like Particles Market Analysis
6.1         South America Virus-like Particles Market Revenue Forecast and Analysis
7.           South America Virus-like Particles Market Analysis – by Product Type
7.1         Overview
7.2         South America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
7.3         Hepatitis
7.3.1        Overview
7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.4         Cancer/ Human Papillomavirus (HPV)
7.4.1        Overview
7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
7.5         Gaucher Disease
7.5.1        Overview
7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.           South America Virus-like Particles Market Analysis – By Source
8.1         Overview
8.2         South America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
8.3         Yeast
8.3.1        Overview
8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.4         Plant
8.4.1        Overview
8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.5         Insect Cell
8.5.1        Overview
8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
8.6         Others
8.6.1        Overview
8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.           South America Virus-like Particles Market Analysis – By Application
9.1         Overview
9.2         South America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
9.3         Vaccines
9.3.1        Overview
9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
9.4         Therapeutics
9.4.1        Overview
9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
10.        South America Virus-like Particles Market – Country Analysis
10.1      Overview
10.1.1     South America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
10.1.1.1       Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.1       Overview
10.1.1.1.2       Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.3       Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4       Brazil Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)
10.1.1.1.5       Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2       Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.1       Overview
10.1.1.2.2       Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.3       Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4       Argentina: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)
10.1.1.2.5       Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3       Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1       Overview
10.1.1.3.2       Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3       Rest of South America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4       Rest of South America: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)
10.1.1.3.5       Rest of South America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11.        Impact Of COVID-19 Pandemic on South America Virus-like Particles Market
11.1      Impact Assessment of COVID-19 Pandemic
12.        South America Virus-like Particles Market–Industry Landscape
12.1      Overview
12.2      Organic Developments
12.2.1     Overview
12.3      Inorganic Developments
12.3.1     Overview
13.        Company Profiles
13.1      Merck & Co., Inc.
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2      GlaxoSmithKline plc.
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3      Pfizer Inc.
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4      Sanofi
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5      Serum Institute of India Pvt. Ltd.
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6      BHARAT BIOTECH
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7      LG Chem
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
14.        Appendix
14.1      About The Insight Partners
14.2      Glossary of Terms

LIST OF TABLES
Table 1.             South America Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)
Table 2.             Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 3.             Brazil Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 4.             Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5.             Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 6.             Argentina: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 7.             Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 8.             Rest of South America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 9.             Rest of South America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 10.          Rest of South America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11.          Organic Developments Done by Companies
Table 12.          Inorganic Developments Done by Companies
Table 13.          Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES
Figure 1.           South America Virus-like particles Market Segmentation
Figure 2.           South America Virus-like particles Market Segmentation, By Country
Figure 3.           South America Virus-like Particles Market Overview
Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in South America Virus-like particles Market
Figure 5.           Brazil to Show Significant Growth during Forecast Period
Figure 6.           South America Virus-like Particles Market, Industry Landscape
Figure 7.           South America PEST Analysis
Figure 8.           South America Virus-like Particles Market: Impact Analysis of Drivers and Restraints
Figure 9.           South America Virus-like Particles Market– Revenue Forecast and Analysis to 2028
Figure 10.        South America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)
Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)
Figure 14.        South America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)
Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19.        South America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)
Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22.        South America Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 23.        South America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)
Figure 24.        Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25.        Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26.        Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27.        Impact Of COVID-19 Pandemic in South America Country Markets

Merck & Co., Inc.
GlaxoSmithKline plc.
Pfizer Inc.
Sanofi
Serum Institute of India Pvt. Ltd.
BHARAT BIOTECH
LG Chem

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South America virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South America virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South America market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022

South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,.. May 2022

South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring.. May 2022

Report Name	Published Date
South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,..	May 2022
South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.